课题基金 / 基金详情

Prognostic and Therapeutic Utility of Human Antigen R (HuR) in Fibrosis

Prognostic and Therapeutic Utility of Human Antigen R (HuR) in Fibrosis
人类抗原 R (HuR) 在纤维化中的预后和治疗效用
批准号：
407811
负责人：
Baglole Carolyn
金额：
$60.75万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-09-01 至 2024-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=407811&lang=en
关键词：
Fibroblast Fibrosis Lung Myofibroblast

项目摘要

项目成果

Baglole Carolyn的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pulmonary fibrosis occurs when the lung becomes scarred and stiffened, leading to death from respiratory failure. The average survival of an individual with pulmonary fibrosis is only 3-5 years, worse than many types of cancer. One of the reasons is that
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Decoding how the aryl hydrocarbon receptor (AhR) controls cigarette smoke-induced lung inflammation and development of chronic obstructive pulmonary disease (COPD)
Immunological consequences of inhaled cannabis and selected cannabinoids
Molecular regulation of cigarette smoke-induced pulmonary disease by the aryl hydrocarbon receptor
海外基金